“Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations with Treatment Resistance in Clear Cell and Nonclear Cell Tumors”, jkcvhl, vol. 12, no. 2, pp. 37–45, May 2025, doi: 10.15586/jkcvhl.v12i2.386.